BLAC Bellevue Life Sciences Acquisition Corp

Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Bellevue Life Sciences Acquisition Corp market cap is $61.35M.

52 week high is the highest price of a stock in the past 52 weeks, or one year. Bellevue Life Sciences Acquisition Corp 52 week high is $11.60 as of May 11, 2024.

52 week low is the lowest price of a stock in the past 52 weeks, or one year. Bellevue Life Sciences Acquisition Corp 52 week low is $10.17 as of May 11, 2024.

Bellevue Life Sciences Acquisition Corp stock price today is $10.91.

Bellevue Life Sciences Acquisition Corp stock price yesterday was $10.80.

The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Bellevue Life Sciences Acquisition Corp’s P/E ratio is 281.19.

The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Bellevue Life Sciences Acquisition Corp P/B ratio is 1.8865.

EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Bellevue Life Sciences Acquisition Corp's EBITDA is -32.24.

The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Bellevue Life Sciences Acquisition Corp 50-day moving average is $10.69.

Bellevue Life Sciences Acquisition Corp has 2 employees.